Science


Posts filtered by tags: Dispensed[x]


 

FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19

A nurse prepares to inject staff with the Pfizer/BioNTech coronavirus vaccine. Liam McBurney/PA Images via Getty Images The FDA authorized boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and people at higher risk. Booster shots are likely to be available in locations like pharmacies and clinics at no cost. The US is still struggling to convince many people to get their first doses of coronavirus vaccines. See more stories on Insider's business page. The US coronavi...
Tags: Science, News, Cdc, Israel, US, Trends, Joe Biden, United States, Healthcare, Delta, Food And Drug Administration, National Institutes of Health, Fda, Pfizer, Biden, Centers For Disease Control And Prevention


A massive study from Israel suggests older adults were far less likely to develop severe COVID-19 after a booster shot, but the finding carries major limitations

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP A third dose of Pfizer's coronavirus vaccine dramatically reduces the risk of infection and severe illness for older adults, a new study found. A team of researchers in Israel published the findings Wednesday in The New England Journal of Medicine. Still, an expert urged caution on interpreting the findings, saying the study...
Tags: Health, Science, News, Israel, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, Murray, New England Journal of Medicine, Tel Aviv Israel


FDA releases documents outlining Pfizer's case for COVID-19 booster shots

Vials of the Pfizer-BioNTech Covid-19 vaccine. Patrick Fallon/AFP via Getty Images The FDA released documents Wednesday giving a look at Pfizer's case for COVID-19 booster shots. The data shows a third dose of Pfizer's shot raised antibody levels with no major safety concerns. An expert panel will make recommendations to the FDA on booster shots on Friday. See more stories on Insider's business page. The US Food and Drug Administration published documents on Wednesday that prov...
Tags: Health, UK, Science, News, Cdc, Trends, Healthcare, Delta, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, US Food and Drug Administration, Pharmaceutical, Andrew Dunn


The most common side effects to expect after your Pfizer booster: headache, fatigue, and pain at the injection site

A health worker administers the Pfizer vaccine in the Palestinian neighborhood of Beit Hanina, in the Israeli-annexed east Jerusalem, on August 29, 2021. Ahmad Gharabli/AFP/Getty Images Pfizer's COVID-19 booster shot yields mild to moderate side effects, much like its second dose. Injection-site pain is most common after a booster, according to data released Wednesday. People who received a third dose of Pfizer's vaccine also frequently reported headaches and fatigue. See more stor...
Tags: Science, News, Israel, US, Jerusalem, Trends, Walgreens, Healthcare, Food And Drug Administration, Miami, Fda, Pfizer, Symptoms, Lancet, Los Angeles County, Side Effects


The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data

President Joe Biden speaks about prescription drug prices and his "Build Back Better" agenda from the East Room of the White House, Thursday, Aug. 12, 2021, in Washington. Associated Press/Evan Vucci The heads of the FDA and CDC are pushing back on the White House's plan for COVID-19 booster shots. The top health officials say they need more time to review data on extra doses, . It's the latest setback to the Biden administration's booster plan, which has also prompted resigna...
Tags: Health, Science, News, Cdc, White House, US, Trends, Joe Biden, Healthcare, The Times, Fda, Pfizer, Biotech, Biden, Times, Johnson Johnson


Pfizer's CEO tell us why he thinks we'll need COVID-19 vaccines every year, like flu shots

Albert Bourla, CEO of Pfizer Crystal Cox/Skye Gould/Insider People will most likely need annual COVID-19 booster shots, Pfizer CEO Albert Bourla told Insider. It's another sign that we'll be dealing with the novel coronavirus for years to come. The pharma exec highlighted the risk of new variants emerging and vaccine protection waning. See more stories on Insider's business page. Pfizer CEO Albert Bourla predicted in a Wednesday interview that people will most likely need annua...
Tags: Health, Science, News, US, Trends, Healthcare, Food And Drug Administration, World Health Organization, Fda, Pfizer, Pharmaceutical, Moderna, Andrew Dunn, Albert Bourla, Bourla, Hilary Brueck


The pandemic created a bunch of biotech billionaires. Take our 5-question quiz to see how well you know the pay trends shaping the drug industry.

From left: Stephane Bancel of Moderna, Leonard Schleifer of Regeneron, and Stanley Erck of Novavax. Steven Ferdman/Getty Images; Adam Jeffery/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images; Novavax; Skye Gould/Insider Several biotech executives became billionaires last year, as the pandemic drove vaccine sales and stock market fervor. How did that wealth trickle down through the industry? See if you can guess what executives and employees earned. This quiz is part of Insider's deep...
Tags: Science, News, Trends, Getty Images, Compensation, Healthcare, Pay Gap, Biotech, Sawyer, Pharmaceutical, Novavax, Regeneron, Skye Gould, Stanley Erck, Stéphane Bancel, Salary Data


Delta's surging and antibodies are waning: What to know about when we'll need COVID-19 booster shots

Moderna has soared over the past year on the back of its coronavirus vaccine. Radek Mica/Getty Images Should the US start offering people an extra COVID-19 vaccines dose? Supporters cite signs of waning protection and data suggesting a booster shot would help. Others say boosting now is unnecessary, because the shots still prevent hospitalizations and death. See more stories on Insider's business page. The debate over whether the US should roll out extra doses of coronavirus vaccines...
Tags: Health, Science, Cdc, France, Germany, Israel, Nbc News, US, Trends, Analysis, Healthcare, Delta, World Health Organization, Philadelphia, Fda, Pfizer


Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year

Skye Gould/Insider Irene Jiang/Business Insider An Insider analysis of 182 biotech and pharma companies revealed that 92% of CEOs are men. The lack of diversity in the drug industry's CEO ranks costs women an estimated $532 million a year. Drug industry CEOs and other experts said equity is achievable if companies make it a priority. This article is part of a series called "The Cost of Inequity," examining the hurdles that marginalized and disenfranchised groups face acr...
Tags: Health, Science, Boston, Trends, Healthcare, Biotech, Gender Diversity, Bio, Anderson, Gilead Sciences, Cooke, Pharmaceutical, Brainard, Veracyte, Third Rock Ventures, Bonnie Anderson


CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech

An employee of German biopharmaceutical company CureVac. REUTERS/Andreas Gebert CureVac's experimental COVID-19 vaccine failed in a pivotal clinical study, the biotech said Wednesday. It's the first late-stage study to flop, with CureVac's vaccine showing 47% effectiveness. The German biotech saw its stock price drop by more than 50% in post-market trading. See more stories on Insider's business page. A COVID-19 vaccine candidate developed by the German biotech CureVac f...
Tags: Health, Science, Trends, Healthcare, Vaccine, Biotech, Bill Melinda Gates Foundation, CureVac, Andrew Dunn, Coronavirus, COVID, Dispensed, Andreas Gebert, Franz Werner Haas


Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use

lechatnoir/Getty Images Novavax said its coronavirus vaccine was 90% effective at preventing COVID-19. The shot succeeded in a study that enrolled almost 30,000 volunteers in the US and Mexico. The Maryland biotech plans to ask US regulators for permission to give the shot more widely. See more stories on Insider's business page. The biotech company Novavax said on Monday that its coronavirus vaccine succeeded in a final-stage clinical trial, demonstrating 90% efficacy at preventing...
Tags: Health, UK, Science, News, Maryland, Mexico, US, Trends, South Africa, Healthcare, Astrazeneca, Biotech, Johnson Johnson, Pharmaceutical, Novavax, Gaithersburg Maryland


4 coronavirus variants can make people sicker or spread faster, including the Delta variant first found in India. Here's what variants are, and why experts are so concerned about them.

A health worker takes a swab from a man's nose through a glass shield (for safety) in New Delhi, India, on August 8, 2020. Rapid antigen tests for COVID-19 are being provided by the Indian government for free. Pradeep Gaur/SOPA Images/LightRocket via Getty Images There are four coronavirus variants, including the Delta variant, that experts around the world are particularly worried about. These variants were first identified in South Africa, the UK, Brazil, and India respectively. Othe...
Tags: Health, Japan, UK, New York, Science, London, California, Cdc, India, New York City, Israel, US, Trends, Taiwan, South Africa, Philippines


The FDA just approved the first new Alzheimer's drug in 18 years

Dr. William Burke going over a PET brain scan at Banner Alzheimer's Institute in Phoenix. Biogen's drug was tested against carriers of the APOE gene, which is linked to Alzheimer's, and non-carriers. Matt York/Associated Press The FDA on Monday approved the first new Alzheimer's disease treatment in nearly two decades. Biogen had initially deemed the drug a failure and shut down two late-stage trials. Experts were divided on the drug. One analyst had estimated a 15% chance ...
Tags: Science, News, Trends, Alzheimer's Disease, Healthcare, Food And Drug Administration, Fda, Biotech, Agency, Citi, Alzheimer, William Burke, RBC Capital Markets, Biogen, Eli Lilly, Namenda


3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond

A medical assistant administers a COVID-19 vaccine dose to a woman at a clinic in Los Angeles on March 25, 2021. Mario Tama/Getty Images Coronavirus vaccines have been a stunning success story of the pandemic. But there are still a few key unanswered questions about the COVID-19 vaccines we have. Some of the biggest: How long does vaccine protection last, and how good will it be against new variants? See more stories on Insider's business page. Hot vax summer is here.More than half o...
Tags: Science, News, Cdc, India, New York City, US, Toronto, Los Angeles, Trends, South Africa, Healthcare, Poland, World Health Organization, Fda, University of Pennsylvania, Pfizer


4 coronavirus variants can make people sicker or spread faster, including the variant first found in India. Here's what variants are, and why experts are so concerned about them.

People wearing masks in Del Mar, California. There are four coronavirus variants that experts around the world are particularly worried about. These variants were first identified in South Africa, the UK, Brazil, and India respectively. Others coronavirus variants have concerning features, but it's not yet clear they're more dangerous. See more stories on Insider's business page. Several coronavirus variants have evolved mutations that mean they spread more easily, make peopl...
Tags: Health, Japan, UK, New York, Science, London, California, Cdc, India, New York City, Israel, US, Trends, Taiwan, South Africa, Philippines


German scientists say they've figured out why AstraZeneca and Johnson & Johnson's COVID-19 vaccines can cause rare, unusual blood clots

A pharmacist at the Hartford Hospital in fills a syringe with the Johnson & Johnson COVID-19 vaccine. Joseph Prezioso/Getty Images Scientists say they've figured out how AstraZeneca's and Johnson & Johnson's COVID-19 vaccines can cause blood clots. They say the vaccines cause "mutant" proteins to escape cells in the body, triggering a response in blood vessels. The theory hasn't been proven or scrutinized by experts. Other theories exist. See more stories on Insider's b...
Tags: Health, Science, Trends, Healthcare, Astrazeneca, Pfizer, Johnson, Ball, Bristol University, FRANKFURT Germany, Johnson & Johnson, European Medicines Agency, University of Nottingham, EMA, Janssen, Goethe University


Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK

A coronavirus vaccine trial volunteer receives a shot. Glenn Asakawa/University of Colorado Moderna's coronavirus vaccine likely works in teens, according to study results that the biotech plans to submit to regulators next month. The vaccine could become the second OK'd for people as young as 12. Teens in Moderna's study had similar immune responses as adults who received the shot. See more stories on Insider's business page. Moderna's coronavirus vaccine appears to be...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Pfizer, Biotech, US Food and Drug Administration, Pharmaceutical, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine, Dispensed


Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

Sanofi CEO Paul Hudson Reuters Sanofi and GlaxoSmithKline said that their experimental COVID-19 vaccine succeeded in a mid-stage trial. The pharma giants plan to launch a pivotal-stage study with 35,000 volunteers in the coming weeks. The shot suffered from disappointing data and delays in 2020. The companies now hope for approval by year's end. See more stories on Insider's business page. One of the world's most closely watched coronavirus vaccine programs reported positive d...
Tags: Health, Science, Microsoft, US, Trends, Healthcare, GlaxoSmithKline, Johnson Johnson, Sanofi, GSK, Pharmaceutical, Andrew Dunn, Emma Walmsley, Coronavirus, Coronavirus Vaccine, Dispensed


4 coronavirus variants can make people sicker or spread faster, including the variant first found in India. Here's why experts are so concerned about mutant strains.

People wearing masks in Del Mar, California. There are four coronavirus variants that experts around the world are particularly worried about. These variants were first identified in South Africa, the UK, Brazil, and India respectively. Others coronavirus variants have concerning features, but it's not yet clear they're more dangerous. See more stories on Insider's business page. Several coronavirus variants have evolved mutations that mean they spread more easily, make peopl...
Tags: Health, Japan, UK, New York, Science, London, California, Cdc, France, India, New York City, Nigeria, Israel, US, Trends, Taiwan


3 coronavirus variants can make people sicker or spread faster - and experts are monitoring others, including one spreading in India

People wearing masks in Del Mar, California. There are three coronavirus variants that experts around the world are worried about. These include variants first identified in South Africa, the UK, and Brazil. Others variants, like one first found in India, have concerning features, but it's not yet clear they're more dangerous. See more stories on Insider's business page. Several coronavirus variants have evolved mutations that mean they spread more easily, make people sicker,...
Tags: Health, Japan, UK, New York, Science, London, California, Cdc, France, India, New York City, Nigeria, Israel, US, Trends, Taiwan


3 coronavirus variants can make people sicker, evade the immune response, or spread faster - and experts are monitoring others, including one spreading in India

People wearing masks in Del Mar, California. There are three coronavirus variants that experts around the world are worried about. These include variants first identified in South Africa, the UK, and Brazil. Others variants, like one first found in India, have concerning features, but it's not yet clear they're more dangerous. See more stories on Insider's business page. Several coronavirus variants have evolved mutations that mean they spread more easily, make people sicker,...
Tags: Health, Japan, UK, New York, Science, London, California, Cdc, France, India, New York City, Nigeria, Israel, US, Trends, Taiwan


The US is resuming its rollout of Johnson & Johnson's vaccine after a pause to investigate blood clots

Nurse Elizabeth Johnson administers a COVID-19 vaccine to Melissa Mendez in Reading, Pennsylvania. Ben Hasty/MediaNews Group/Reading Eagle/Getty Images The US will resume using Johnson & Johnson's coronavirus vaccine. The decision came after a CDC committee voted to recommend using the shots. The US paused its rollout on April 13, citing concerns over rare blood clots. See more stories on Insider's business page. The US will resume using Johnson & Johnson's COVID-19 vaccine, m...
Tags: Europe, Science, News, Cdc, US, Trends, Pennsylvania, Healthcare, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Vaccine, Johnson, Baltimore, Johnson & Johnson


Moderna's mRNA technology could help in the decades-long search for an HIV vaccine

Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021. While "excited" by the prospect, HIV researchers caution there's a long road ahead for mRNA vaccines....
Tags: Science, Massachusetts, New York City, Trends, Thailand, South Africa, Healthcare, University of Pennsylvania, Pfizer, Lincoln Center, Biotech, National Bureau of Economic Research, Nih, Frank, Emory University, Johnson Johnson


4 virus variants are spreading in the US, and studies suggest they can make people sicker, evade the immune response, or spread faster. Here's why experts are concerned.

Dr. Anthony Fauci in Washington, DC, on February 25, 2021. Saul Loeb /AFP via Getty Images There are four coronavirus variants that experts in the US are worried about. These include variants first identified in South Africa, the UK, and Brazil. They may spread more easily, make people sicker, escape immune responses, evade tests, or render treatments ineffective, studies suggest. See more stories on Insider's business page. Several coronavirus variants have evolved mutations that mean...
Tags: Health, Japan, UK, New York, Science, News, California, Cdc, India, Israel, US, Trends, Taiwan, South Africa, Washington Dc, Healthcare


We asked experts what they make of the J&J vaccine pause

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We asked experts what to make of the J&J vaccine pause;Our reporter tried to find out how much it'd cost to get an MRI - and it turned into a real headache;Microsoft's $16 billion bid for Nuance gets it in on the ground floor of healthcare.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... J...
Tags: Google, Amazon, Science, Microsoft, US, Trends, Hospitals, Healthcare, Astrazeneca, Pfizer, Vaccine, Johnson Johnson, Shelby, Nuance Communications, Health IT, Blood Clots


Doctors say fears of blood clots from J&J's shot are overdone and could delay the push to end the pandemic

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images Coronavirus vaccines are facing their biggest safety scare to date. A small number of people immunized with Johnson & Johnson's or AstraZeneca's shot developed serious blood clots. Medical experts say a blow to public confidence in vaccination is a graver threat than the actual adverse events. See...
Tags: Health, Europe, Science, News, Cdc, US, Trends, Healthcare, Astrazeneca, Fda, Pfizer, Centers For Disease Control And Prevention, Johnson & Johnson, US Food and Drug Administration, Gandhi, Los Angeles California


New data shows Moderna's vaccine remains highly protective 6 months after shots

A nurse administers a dose of the Moderna vaccine in Los Angeles, California. Mario Tama/Getty Images Moderna said Tuesday its vaccine was 90% effective in protecting people from COVID-19 six months after their shots. The results were on par with the long-term benefits of Pfizer's vaccine. A special booster shot developed for the B.1.351 variant out of South Africa is showing promising preclinical signs. See more stories on Insider's business page. Moderna's COVID-19 vaccine re...
Tags: Science, US, Trends, South Africa, Healthcare, Pfizer, Vaccine, Variant, Los Angeles California, Moderna, Stéphane Bancel, BioNtech, Coronavirus, COVID, Dispensed, Allison DeAngelis


The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing concerns over rare blood clots

A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vaccine. Stephen Zenner/SOPA Images/LightRocket via Getty Images The CDC and the FDA have recommended pausing the rollout of J&J's single-dose COVID-19 vaccine. They cited an "abundance of caution" related to six cases of blood clots in people who got the shot. The US has administered 6.8 million doses of the vaccine so far. See more stories on Insider's business page. The US is putting an immediate pause on ...
Tags: Health, Europe, Politics, UK, Science, Cdc, White House, US, Trends, Georgia, European Union, Speed, Healthcare, News UK, Food And Drug Administration, Astrazeneca


The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing the risk of rare blood clots

A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vaccine. Stephen Zenner/SOPA Images/LightRocket via Getty Images The CDC and the FDA have recommended pausing the rollout of J&J's single-dose COVID-19 vaccine. They cited an "abundance of caution" related to six cases of blood clots in people who got the shot. The US has administered 6.8 million doses of the vaccine so far. See more stories on Insider's business page. The US is putting an immediate pause on ...
Tags: Health, Europe, Politics, UK, Science, Cdc, White House, US, Trends, Georgia, European Union, Speed, Healthcare, News UK, Food And Drug Administration, Astrazeneca


US officials recommend pausing the Johnson & Johnson coronavirus vaccine rollout immediately, citing the risk of rare blood clots

A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vaccine. Stephen Zenner/SOPA Images/LightRocket via Getty Images The CDC and the FDA have recommended pausing the rollout of J&J's single-dose COVID-19 vaccine. They cited an "abundance of caution" related to six cases of blood clots in people who got the jab. People in the US have received 6.8 million doses of the vaccine so far. See more stories on Insider's business page. The US is recommending an immediat...
Tags: Health, Politics, UK, Science, Maryland, Cdc, US, Trends, Georgia, European Union, Speed, New York Times, Healthcare, News UK, Food And Drug Administration, Astrazeneca



Filters
show more filters
July - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728293031 
August - 2021
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031     
September - 2021
MoTuWeThFrSaSu
  12345
6789101112
13141516171819
20212223242526
27282930